Prostate cancer Board decisions

The Veteran's appeal for a higher evaluation for his service-connected residuals of prostate cancer prior to December 21, 2022 is denied.,The Veteran's appeal for a higher evaluation for his service-connected residuals of prostate cancer since December 21, 2022 is denied.,The Veteran's appeal for an initial compensable evaluation for his service-connected erectile dysfunction is denied.

The Veteran's claim for service connection for prostate cancer, including as due to herbicide agents and secondary to medications for service-connected disabilities, has been denied.

The Veteran's prostate cancer is found to be related to his exposure to contaminated water at Camp Lejeune, and service connection for this condition is granted.

The Board has remanded several issues related to the Veteran's death and accrued benefits, including service connection for prostate cancer and coronary artery disease. The Appellant is also seeking burial benefits.

The Veteran's claims for increased ratings for diabetes mellitus type II with erectile dysfunction and prostate cancer are being remanded due to the need for additional development.,An effective date earlier than August 31, 2010, for the grant of service connection for coronary artery disease has been denied.

The Veteran's prostate cancer is rated at 100% effective April 23, 2020. Prior to that date, he was granted a 20% rating for his residuals of prostate cancer.

The Veteran's service-connected residuals of prostate cancer are rated at 60 percent, and the appeal for a higher rating is denied.,The Veteran's service-connected erectile dysfunction has been increased to 20 percent effective April 8, 2013.

The Veteran's prostate cancer is granted as service connected due to exposure at Camp Lejeune. The Board has also remanded the issues of service connection for bilateral hip, knee, and ankle disorders, as well as lower extremity neuropathies.

The Veteran's cause of death was metastatic prostate cancer. The Board granted service connection for the cause of death based on presumed exposure to herbicide agents during his Vietnam-era service, and also granted accrued benefits for prostate cancer due to herbicide exposure.

The Board has remanded the Veteran's claims for hypertension, kidney failure, diabetes mellitus, type II, and prostate cancer due to potential service connection based on herbicide exposure. The case requires further development including obtaining personnel records and determining if the Veteran was exposed to herbicides during service.

The Veteran's claims for service connection for prostate cancer and a temporary total evaluation are remanded due to the need for additional development, including verification of his alleged exposure to contaminated water at Camp LeJeune.

The Veteran's prostate cancer is being remanded due to insufficient evidence regarding herbicide exposure in Okinawa, Japan. The Board will conduct further investigation into the Veteran's claims.

Service connection for prostate cancer is granted, effective January 27, 2010. The claim was reopened due to new evidence received after the original denial in April 2021.

The Veteran's service-connected disabilities prevented him from obtaining and maintaining substantially gainful employment since September 19, 2017.

The Board denied service connection for diabetes mellitus, type II and prostate cancer based on the Veteran's exposure to herbicide agents in Korea. The evidence did not support his claims of exposure or associated injuries.

The Board has granted service connection for PTSD and remanded the issue of service connection for prostate cancer.

The Veteran's service connection claim for prostate cancer is granted due to exposure to herbicides during his active duty at Ubon Royal Thai Air Force Base (RTAFB). Prostate cancer is presumed to be linked to such exposure.

The Board has reopened the Veteran's claims for prostate cancer and bilateral hearing loss due to new evidence. The issues of service connection for tinnitus, thoracic cage blood clots, erectile dysfunction (secondary to prostate cancer), and an acquired psychiatric disorder are remanded for further development.

The Veteran's claims for a compensable disability rating for prostate cancer and a disability rating in excess of 10 percent for left ankle fracture are being remanded due to the need for more contemporaneous examinations.

The Veteran's appeal regarding the reduction of his prostate cancer disability rating from 100 percent to 40 percent was denied. The Veteran also sought an increased rating for his residuals of prostate cancer, which were denied.,A disability rating in excess of 60 percent effective June 8, 2022, for residuals of prostate cancer was denied.